Thibaut Roulon

Thibaut started his career as a scientist with a US biotech company developing cancer immunotherapeutics. In 2005 he joined Bioam Gestion, a venture capital firm investing in life science companies. In 2010, Bioam merged with Bpifrance Investissement (formerly known as CDC Entreprises), a leading French investment firm investing in SMEs and mid-Tier companies. He is in charge of managing investments in life sciences companies (Seed, Venture, IPO, PIPE). Thibaut is a graduate of the Ecole Centrale de Paris and holds a PhD from the Pierre & Marie Curie University.